Ely Benaim

Insider Reports History

Entity
Individual
Location
C/O Rexahn Pharmaceuticals, Inc., 15245 Shady Grove Road, Suite 455, Rockville, MD
Signature
/s/ Steven Robbins Attorney in Fact for Ely Benaim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ely Benaim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Chief Medical Officer Ordinary Shares 28.8K $364K $12.65 Jan 6, 2023 Direct

Insider Reports Filed by Ely Benaim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVCR NovoCure Ltd Jan 6, 2023 1 $6.11K 4 Jan 10, 2023 Chief Medical Officer
NVCR NovoCure Ltd Aug 3, 2022 2 -$439K 4 Aug 4, 2022 Chief Medical Officer
NVCR NovoCure Ltd Aug 2, 2022 1 -$30.4K 4 Aug 3, 2022 Chief Medical Officer
NVCR NovoCure Ltd Jul 5, 2022 1 $13.1K 4 Jul 7, 2022 Chief Medical Officer
NVCR NovoCure Ltd May 10, 2022 2 -$266K 4 May 12, 2022 Chief Medical Officer
NVCR NovoCure Ltd Mar 3, 2022 5 $2.72M 4 Mar 7, 2022 Chief Medical Officer
NVCR NovoCure Ltd Jan 6, 2022 1 $3.51K 4 Jan 12, 2022 Chief Medical Officer
NVCR NovoCure Ltd Aug 3, 2021 1 -$69.7K 4 Aug 4, 2021 Chief Medical Officer
NVCR NovoCure Ltd Jul 30, 2021 4 -$129K 4 Aug 3, 2021 Chief Medical Officer
NVCR NovoCure Ltd Jul 6, 2021 1 $12.3K 4 Jul 8, 2021 Chief Medical Officer
NVCR NovoCure Ltd May 27, 2021 3 -$279K 4 May 28, 2021 Chief Medical Officer
NVCR NovoCure Ltd May 12, 2021 1 -$351K 4 May 14, 2021 Chief Medical Officer
NVCR NovoCure Ltd May 10, 2021 4 -$668K 4 May 12, 2021 Chief Medical Officer